Terry Rosen - Chief Executive Officer, Arcus Biosciences, Inc

As of June 21, 2021


Terry Rosen Net Worth

  • Net worth is estimated to be at least $8.86M
  • Owns at least 589,566 units of Arcus Biosciences, Inc stock
  • Sold an estimated value of $211.01K in the last 3 years at Arcus Biosciences, Inc

Terry Rosen Compensation at Arcus Biosciences, Inc in 2020

  • Earned a $325,625 salary
  • Rewarded $2,351,475 in stock value and options
  • Received a total compensation of $5,683,300

Terry Rosen Trading

  • Largest purchase of shares was 2,542,320 units , worth over $1M on March 19, 2018
  • Largest sale of shares was 8,831 units , worth over $211.01K on June 21, 2021
  • In total has made about 15 transactions over 3 years
  • Usually trades in August, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Terry Rosen Mailing Address

  • Mailing address is C/o Tulark Inc Two Corp Drive S San Francisco CA 94080 CA

Arcus Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Terry Rosen, Ph.D. 2020 $325,625 - $2,351,475 $2,351,475 - $1,200 $5,683,300
Terry Rosen, Ph.D. 2019 $340,000 - $1,375,700 $1,375,700 - $1,200 $1,716,900
Jennifer Jarrett 2020 $125,000 - $10,578,439 $10,578,439 $75,000 $28,171 $10,896,760
William Grossman, M.D., Ph.D. 2020 $457,600 - $2,073,420 $2,073,420 $250,000 $1,200 $6,134,970
William Grossman, M.D., Ph.D. 2019 $296,667 $200,000 $2,723,040 $2,723,040 $180,000 $600 $3,400,307
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1724521/000156459021019630/rcus-def14a_20210603.htm

Arcus Biosciences, Inc Insider Trading

  • The most recent transaction was 47,500 units sold on September 22, 2021 by Jennifer Jarrett worth over $1.68M
  • In the last 3 years, insiders at Arcus Biosciences, Inc sold an estimated value of $3.06M and bought an estimated value of $227.36M
  • The most active traders are Terry Rosen, Chief Executive Officer,  Juan Jaen, President,  and William Grossman, Chief Medical Officer
  • Insider trading is most common in June, with the busiest year in 2021

Arcus Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1